investing at the Intersection of tech and bio
OUR THESIS
The first decades of the 21st century brought radical advancements in our understanding of human biology. Sequencing the human genome has unlocked our ability to predict disease and long term health outcomes. The intersection of artificial intelligence and biology has ushered in an era of unprecedented developments in pharmaceuticals, therapeutics, and the diagnosis and prognosis of disease. The emerging bio economy has profound ramifications for manufacturing, climate technology, agriculture, space and human health
2023
launched
27
startups
14
funds
OUR FOCUS
Modi Ventures invests in funds and founders at the intersection of technology and biology and at the forefront of the emergent bioeconomy. We make early stage investments in technology platforms that have a positive impact on health. This includes a deep focus on opportunities that leverage AI, microfluidics (hardware), multiomics, precision medicine, synbio, gene editing, and living therapies.
our Insights
Biology combined with the power of AI will revolutionize health and medicine
SAHIR ALI
Selected portfolio companies
Our portfolio consists of funds and startups at the intersection of technology and biology.
